Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.3
2.6
Journals
Medicina
Special Issues
Advances in Acute Coronary Syndrome Diagnosis and Management
share announcement

Advances in Acute Coronary Syndrome Diagnosis and Management

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 417

Special Issue Editor

Dr. Ibadete Bytyçi

E-Mail Website
Guest Editor
1. Department of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden
2. Clinic of Cardiology, University Clinical Centre of Kosova, 10000 Prishtina, Kosovo
Interests: atherocslerosis; myocardial infarction; premature myocardial infarction; dyslipidemia; heart failure; atrial fibrillation; echocardiography; cardiomyopathies; left atrium funciton; cardiac function; hypertension

Special Issue Information

Dear Colleagues,

Recent strides in the diagnosis and management of acute coronary syndrome (ACS) have markedly improved patient outcomes. Innovations, such as high-sensitivity cardiac troponin assays and advanced imaging, enhance ACS identification, crucial for timely intervention and mortality reduction. Risk stratification models assist healthcare professionals in tailoring treatment strategies to individual patient profiles, optimizing care delivery.

In the management of ACS, there is a notable shift toward comprehensive and personalized approaches. This encompasses the use of antiplatelet agents, anticoagulants and invasive procedures tailored to patient-specific characteristics. The integration of guideline-directed medical therapy with invasive interventions has demonstrated positive outcomes, underscoring the significance of a collaborative, multidisciplinary approach. Involving cardiologists, emergency physicians and various healthcare providers ensures timely and effective care for ACS patients, emphasizing the importance of teamwork in critical situations. Exploring novel technologies, treatment modalities and interdisciplinary collaborations will further shape the evolving landscape of ACS care, contributing to ongoing improvements in patient outcomes and overall cardiovascular health.

Dr. Ibadete Bytyçi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • acute coronary syndrome
  • novel technologies
  • treatment modalities
  • risk stratification models

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

11 pages, 609 KiB  
Article
The Effect of Iodinated Contrast Media Sensitivity on the Prognosis of Patients with STEMI
by Alon L. Roguin, Edo Y. Birati and Ofer M. Kobo
Medicina 2024, 60(6), 973; https://doi.org/10.3390/medicina60060973 - 12 Jun 2024
Viewed by 179
Abstract
Abstract: Background and Objectives: Iodinated Contrast Media (ICM) is used daily in many imaging departments worldwide. The main risk associated with ICM is hypersensitivity. When a severe hypersensitivity reaction is not properly managed and treated swiftly, it may be fatal. Currently, [...] Read more.
Abstract: Background and Objectives: Iodinated Contrast Media (ICM) is used daily in many imaging departments worldwide. The main risk associated with ICM is hypersensitivity. When a severe hypersensitivity reaction is not properly managed and treated swiftly, it may be fatal. Currently, there is no data to demonstrate how ICM sensitivity affects the prognosis of cardiac patients, especially those diagnosed with ST elevation myocardial infarction (STEMI), in whom urgent coronary angiography is indicated. This study aimed to identify and characterize this relationship. Materials and Methods: We included patients hospitalized with STEMI between 2016 and 2019 from the National Inpatient Sample. The population was compared based on ICM sensitivity status, sensitive vs. non-sensitive. The primary endpoint was in-hospital mortality, with additional endpoints: length of stay and in-hospital complications. Results: The study included 664,620 STEMI patients, of whom 4905 (0.7%) were diagnosed with ICM sensitivity. ICM-sensitive patients were older, more often white, females, and had more comorbidities and cardiovascular risk factors. Both groups show similarities in management but are slightly less probable to undergo PCI or CABG. Multivariable logistic regression models found that the ICM-sensitive population had similar odds of in-hospital mortality (OR: 1.02, 95% CI: 0.89–1.16) and MACCE (OR: 1.05, 95% CI: 0.95–1.16), and less major bleeding (OR: 0.73, 95% CI: 0.60–0.87). Conclusions: Our study found that ICM sensitivity status was not a significant factor for worse prognosis in patients hospitalized with STEMI. Full article
(This article belongs to the Special Issue Advances in Acute Coronary Syndrome Diagnosis and Management)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop